...
首页> 外文期刊>Biochemistry >Ligand Binding Domain Mutations of the Glucocorticoid Receptor Selectively Modify the Effects with, but Not Binding of, Cofactors
【24h】

Ligand Binding Domain Mutations of the Glucocorticoid Receptor Selectively Modify the Effects with, but Not Binding of, Cofactors

机译:糖皮质激素受体的配体结合结构域突变选择性地改变官方acactors的助剂,但不具有辅助act

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We previously reported that several point mutations in the ligand binding domain (LBD) of glucocorticoid receptors (GRs) marginally affect the binding affinity of the synthetic glucocorticoids dexamethasone (Dex) and deacylcortivazol (DAC). However, these mutations dramatically alter the efficacy (A_(max)) and potency (EC_(50)) of agonists, along with the partial agonist activity (PAA) of the antisteroid Dex-mesylate (DM), for gene induction and repression in a steroid-dependent manner. This was proposed to result, in part, from altered protein protein interactions in the complex of GR with the coactivator TIF2 despite normal TIF2 binding. To explore the generality of this phenomenon, we now ask whether these mutations also affect the transactivation properties, but not binding, of other GR-bound factors. We find that an elevated concentration of GR, to probe unidentified cofactors, or of the comodulator Ubc9 does not reverse the effects of GR LBD mutations that increase the EC_(50) and lower the PAA with the GREtkLUC reporter in both CV-1 and U2OS cells. This behavior is more dramatic with Ubc9 and the isolated GR LBD fused to the GAL4 DNA binding domain, despite normal binding of Ubc9 to the mutant GRs. Similar effects, albeit gene, steroid, and transcriptional property-specific, are seen with full-length GRs and three endogenous genes in U2OS cells. Thus, changes in simple steady-state binding capacities of mutant receptors for factors cannot account for the modified transcriptional properties. In all cases, the nuclear translocation of Dex- and DAC-bound wild-type and mutant receptors is the same. These results are consistent with the earlier results with TIF2 and support the hypothesis that small changes in the GR LBD can alter the activities of the bound cofactor without modifying cofactor binding. We propose that this separation of binding and the modulation of transactivation parameters occurs for a wide variety of GR-associated cofactors.
机译:我们之前报道的是,糖皮质激素受体(GRS)的配体结合结构域(LBD)中的几个点突变略微影响合成糖皮质激素地塞米松(DEX)和DEACELCORVAZOL(DAC)的结合亲和力。然而,这些突变显着改变激动剂的疗效(A_(MAX))和效力(EC_(50))以及所述基因诱导和抑制的所述抗静止DEX-甲磺酸盐(DM)的部分激动剂活性(PAA)类固醇依赖的方式。尽管正常的TIF2结合,这提出了其中部分地从CR族聚合物的复合物中的改变的蛋白质蛋白质相互作用中产生。为了探讨这种现象的一般性,我们现在询问这些突变是否也影响其他GR束缚因子的转移性质,但不具有约束力。我们发现GR的浓度升高,探针未识别的辅助因子或分子器UBC9不逆转GR LBD突变的影响,这些突变增加EC_(50)并在CV-1和U2OS中使用GRETKLUC报告者降低PAA细胞。尽管UBC9与突变遗留族的正常结合,但这种行为与UBC9和融合到GAL4 DNA结合结构域的孤立的GR LBD更戏剧。使用U2OS细胞中的全长GR和三个内源基因来观察类似的效果,虽然基因,类固醇和转录性特异性。因此,因素的突变受体的简单稳态结合能力的变化不能考虑改性转录性质。在所有情况下,Dex-和Dac-Bound的野生型和突变受体的核易位是相同的。这些结果与TIF2的前面结果一致,支持GR LBD的小变化可以改变结合辅因子的活动而不改变辅因子结合的假设。我们提出这种结合和转移参数的调节的这种分离发生了各种GR相关的辅助因子。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号